The European Union has made progress toward overhauling its cosmetics regulations by reaching a provisional accord on the Omnibus VI package. This new agreement, forged between the European Parliament and the European Council following the European Commission’s initial proposal, accelerates the process for withdrawing products containing substances classified as carcinogenic, mutagenic, or toxic to reproduction (CMR).Industry stakeholders have expressed approval, highlighting that the update strengthens legal clarity while maintaining the EU’s high benchmark for consumer protection.
Omnibus VI Agreement to Modernize EU Cosmetic Rules
Members of the European Parliament and the Council have agreed on an updated framework, the Omnibus VI package, that will reshape the regulation of cosmetics across the EU. The deal shortens deadlines for removing cosmetic items with CMR ingredients compared to the European Commission’s original timeline. 
An industry spokesperson emphasized that the revised rules strike a balance between legal clarity and reducing red tape. The Omnibus VI package, the statement explains, gives businesses more certainty and fosters innovation, with science informing the way rules are drafted and enforced.
Shorter Deadlines for Phase-Out of Restricted Products
According to the deal, once a ban is enacted for a given substance, companies must stop introducing affected cosmetics to the market within six months unless specific permission to continue is in place. Products already present on store shelves can continue to be sold for up to 12 months after the ban is effective.
This transition is much faster than what the European Commission previously suggested, which allowed 12 months to place products on the market and up to 24 months for continued sales. Introducing clear but strict time limits addresses gaps existing in the former legislation.
If a manufacturer seeks to use a banned substance,it can apply for an exemption-referred to as a derogation-within a year of the new classification. The clock for phasing out the product only begins after the ruling on this request.
If the derogation is denied for reasons of consumer safety,companies have just three months to halt new product placements and nine months to stop existing sales. If the refusal is because a safer substitute is available, the permitted transition stretches to 24 months for placing products and 36 months for ongoing sales before total withdrawal is required.
No Special Allowance for Certain Exposure Routes
the original proposal from the European Commission suggested that certain CMR risks-if only connected to oral or inhalation exposure-might not require automatic restrictions unless skin exposure was evident. The Parliament and Council did not adopt this carve-out. Under the new compromise, CMR classification, whether the risk comes from ingestion, inhalation, or skin contact, may result in a ban or formal assessment regardless of exposure route. This closes potential regulatory loopholes and strengthens protective measures for consumers.
continued Oversight for Nanomaterials in Cosmetics
The final agreement also preserves the obligation for brands to notify the european Commission before launching products containing nanomaterials. These ultra-fine ingredients appear in various UV filters, pigments, and performance boosters.
While the Commission initially proposed eliminating this notification-citing redundancy-the deal keeps the rule but shortens the pre-market waiting period. this adjustment aids industry, which must now comply with a notification scheme that is less time-consuming but still upholds openness and oversight.
One parliamentarian involved in negotiations stated that the package is an example of regulatory reform that maintains strict protections. The new legislation reduces business burdens, improves access to product safety details, and boosts legal clarity, all without lowering health or environmental safeguards that apply EU-wide.
Further, guidance is scheduled for release within a year of the regulation’s enforcement, directing companies on assessing and switching away from hazardous chemicals. This guidance is expected to pave the way for quicker adoption of safer alternatives in EU cosmetics.
The Omnibus VI package still awaits formal adoption by both the European Parliament and Council, with final rules set to become law 20 days after publication in the Official Journal of the European Union.
Industry Response and Economic Context
After the breakthrough, leading trade bodies representing cosmetics, fragrances, essential oils, cosmetic ingredients, natural products, and SMEs issued a joint statement of support.
According to these associations, the new legislation preserves a high level of consumer protection while making cosmetic regulation clearer and more actionable. They argued that the agreement demonstrates it is indeed possible to uphold safety and continue to support scientific and competitive progress in the sector.
The joint statement also highlighted the sector’s scale and significance. The EU’s personal care and cosmetics industry is valued at €180 billion, with €30 billion in annual exports and more than 3.5 million jobs across the supply chain, making it one of the region’s largest contributors to both employment and trade.
These organizations affirmed that safeguarding consumers remains central to the industry’s mission. They welcomed the Omnibus VI package, calling it a fair move that protects health while reducing needless bureaucracy. They also stressed the importance of evidence-driven, proportionate regulation in supporting the industry’s growth and consumer trust.
